Multi-modality Imaging in Peritoneal Carcinomatosis of Colorectal Origin
Ontology highlight
ABSTRACT: Intraoperative tumor localization and resection can be enhanced using intraoperative fluorescence imaging and radiodetection. Labetuzumab specifically recognizes CEA which is is expressed on > 95% of colorectal cancers.. Therefore Indium-111-DOTA-labetuzumab-IRDye800CW is a perfect dual-labeled antibody for dual-modality image-guided surgery in peritoneal carcinomatosis of colorectal cancer.
DISEASE(S): Peritoneal Neoplasms,Carcinoma,Gastrointestinal Neoplasms,Colorectal Cancer,Gastrointestinal Cancer,Neoplasms,Peritoneal Carcinomatosis
PROVIDER: 2286305 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA